Abstract

Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats var callbackToken='505E71304FE9127'; var subCode='aspet_sub'; Skip to main page content HOME CURRENT ISSUE ARCHIVE FEEDBACK SUBSCRIPTIONS ALERTS HELP Keywords GO Advanced » Institution: DeepDyve Sign In as Member / Individual User Name Password Sign In Epidermal Growth Factor Receptor Inhibitor PKI-166 Governs Cardiovascular Protection without Beneficial Effects on the Kidney in Hypertensive 5/6 Nephrectomized Rats Nadir Ulu , Gemma M. Mulder , Peter Vavrinec , Sjoerd W. Landheer , Basak Duman-Dalkilic , Hakan Gurdal , Maaike Goris , Marry Duin , Richard P. E. van Dokkum , Hendrik Buikema , Harry van Goor , and Robert H. Henning Departments of Clinical Pharmacology (N.U., P.V., S.W.L., M.G., M.D., R.P.E.v.D., H.B., R.H.H.) and Pathology and Medical Biology (G.M.M., H.v.G.), University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands; and Department of Medical Pharmacology, Faculty of Medicine, University of Ankara, Ankara, Turkey (B.D.-D., H.G.) <h3>Address correspondence to:</h3> Dr. Nadir Ulu, Department of Clinical Pharmacology, University of Groningen, University Medical Centre Groningen, A. Deusinglaan 1, Building 3211, Floor 6, 9713 AV Groningen, The Netherlands. E-mail: n.ulu@med.umcg.nl <h2>Abstract</h2> Transactivation of epidermal growth factor